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Summary Salivary assays are increasingly prevalent in behavioral research, and chewing gum is
a widely used sialogogue. Methodological investigations into sialogogues have provided mixed
results, and few of these have incorporated multiple analytes, gums, and genders. To test effects
of gum on salivary testosterone (T), estradiol (E), and immunoglobulin A (IgA) assays, participants
(86 women; 91 men) provided two saliva samples, the first of which was unstimulated. Parti-
cipants were randomly assigned to one of the following seven conditions for the second sample,
which was provided after the first: No Gum or one of six sugar-free gums with one of two flavors
and three brands. This design avoided the confounding of time and condition by comparing
endogenously vs. exogenously induced changes in analytes. Chewing gum significantly decreased
production time for the second saliva samples by 3—6 min, and had very large effects on assay
results, leading to lower IgA and higher T and E in men and women. Variability was large and
differed by gender/sex. Implications include strong gum-assay immunoreactivity, the importance
of gender/sex in methodological investigations, and that immunoreactivity can differ in degree
and direction depending on analytes.
# 2009 Elsevier Ltd. All rights reserved.Salivary measurement has facilitated growth in human beha-
vioral neuroendocrinology (cf. Lipson and Ellison, 1989).
Salivary assays are validated (e.g. Baxendale et al., 1982;
Dabbs et al., 1995; cf. Shirtcliff et al., 2002), show high test—
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doi:10.1016/j.psyneuen.2009.06.009advantageous. Still, concerns exist (e.g. Granger et al.,
2007), e.g. with sialogogues that speed production but
may interact with assays (e.g. Lipson and Ellison, 1989).
Cotton is used but can inflate gonadal hormone readings
(e.g. Shirtcliff et al., 2001). Chewing gum is more inactive
than, e.g. candy (Lipson and Ellison, 1989), but some have
found gum-assay immunoreactivity (Lipson and Ellison, 1989;
Granger et al., 2004; Shirtcliff et al., 2000) though others
have not (e.g. Dabbs, 1991). Some evidence indicates that
time since chewing matters (e.g. Granger et al., 2004) butd.
306 S.M. van Andersother evidence does not (Dabbs, 1991). These studies have
provided important though mixed results.
Given widespread use of sugar-free gum as sialogogues,
verifying inertness is an important consideration. Here, I
examine effects of gum on salivary assays of testosterone
(T), estradiol (E), and immunoglobulin A (IgA) in women and
men, which is important given no previous studies with IgA
and mixed findings with T and E. Including measures of
gonadal steroids and an immune marker also allows for
considering analyte-specific immunoreactivity. This study
employs a rigorous design and analysis, controlling for sample
production such that time and stimulant are not confounded:
participants provide one unstimulated sample and then a
sample that is either unstimulated or gum-stimulated. As
such, this study provides novel and important data about
gum-assay immunoreactivity, taking gender/sex into
account, that applies to contemporary gums and widely used
assays. It remains important to note that results can be assay-
or lab-specific (Lipson and Ellison, 1989), though previous
methodological inquiries have been understood to generalize
beyond the assays employed (e.g. Granger et al., 2004) as
might results from this study.
1. Methods
1.1. Participants
Participants were part of a larger study approved by the
institutional review board (IRB), designed specifically to
include this methodological examination. Participants were
86 women (mean age = 20 years, SD = 3 years) and 91 men
(mean age = 21 years, SD = 3 years), recruited via ads (receiv-
ing financial compensation) and the Psychology Subject Pool
(receiving credit). The data from women using hormonal
contraceptives who volunteered despite selection criteria
and two women who reported being menopausal were not
analysed as per IRB approval; as a result, women’s n by
condition was altered. I use gender/sex throughout this paper
despite the focus on hormones, because differences cannot
knowingly be attributed to biology or gender socialization.
1.2. Procedure and chewing gum
Participants provided two saliva samples in our lab between
13:00 and 18:00 to control for diurnal rhythmicity (Axelsson
et al., 2005). To control effects of producing two samples in
succession and compare endogenous to exogenously induced
changes, sample 1 (S1) was unstimulated and sample 2 (S2)
was stimulated via one of seven randomly assigned condi-
tions: No Gum (i.e. no sialogogue), Orbit Spearmint, Extra
Spearmint, Dentyne Spearmint, Orbit Peppermint, Extra
Peppermint, Dentyne Peppermint. Gums containing aspar-
tame were selected from popular options to ensure a wide
selection. I did not include Trident Original as analyses
already indicate immunoreactivity (Shirtcliff et al., 2000).
1.3. Samples and assays
Saliva (3—4 mL) was collected in 17 mL polystyrene tubes
by spitting after participants rinsed their mouths with
water before S1. Tubes were frozen until assay. Assays wereconducted between 08/2008 and 09/2008 at the Core Bio-
markers Lab at Yerkes Primate Research Center at Emory
University via radioimmunoassay (T, E) and ELISA (IgA). Assays
were from widely used commercially prepared kits from
Salimetrics, LLC (E, IgA) (State College, PA) and Diagnostic
Systems Laboratories (T) (Webster, TX). Assay ranges were: E,
1—32 pg/mL; T, 2—500 pg/mL; IgA, 2.5—600 mg/mL. Inter-
assay coefficients of variation were: E, 7.8% at 0.107 mg/dL,
5.48% at 1.071 mg/dL, and 10.21% at 0.20 mg/dL; T, 19.16% at
5.03 pg/mL, 15.08% at 170.81 pg/mL, and 16.40% at
25.31 pg/mL; IgA, 14.85% at 28.30 pg/mL and 11.68% at
197.06 pg/mL. Intra-assay coefficients of variation were:
E, 10.35% at 0.22 mg/dL; T, 3.41% at 26.89 pg/mL; IgA,
9.96% at 278.10 pg/mL. Outliers (over 3 SD from the mean)
were excluded from relevant analyses.
There were several outliers (over 3 SD from the mean as
well as visually) who were excluded from analyses with those
variables; some of these included extreme outliers that likely
resulted from blood contamination. Outlier numbers were
similar for men (42/819) and women (49/774). For men,
there were four T1 outliers, two T2 outliers, three T% out-
liers, eight E1 outliers (including four too high to be read),
eight E2 outliers (including three too high to be read), three
E% outliers, four IgA1 outliers, four IgA2 outliers, and six IgA%
outliers. For women, there were 12 T1 outliers, two T2
outliers, two T% outliers, 12 E1 outliers (including six too
high to be read), 10 E2 outliers (all too high to be read), two
E% outliers, three IgA1 outliers, two IgA2 outliers, and four
IgA% outliers. Outliers were spread throughout the condi-
tions, including No Gum; outlying values thus did not result
from any gums and eliminating the outliers should not have
introduced any confounds into the analyses. Though there
appears to bemany outliers, not all of which can be explained
by possible blood contamination, the number of outliers per
sample and per hormone (e.g. four T1 outliers from 91men) is
generally in line with previous studies (though the number of
E outliers is higher); outlier number appears higher likely
because there were more samples and more analytes mea-
sured in this study than other recent comparable studies.2. Results
Since my aim was to accept the null hypothesis, statistical
considerations were directed towards avoiding Type II (fal-
sely concluding inertness) rather than Type I error. Accord-
ingly, I conducted multiple independent and paired t-tests.
Analyses were conducted with percent changes (i.e.
[S2  S1]/S1), which are more sensitive in the face of large
variation since they take individual changes into account (van
Anders and Watson, 2007). I also conducted analyses with
absolute values for comparison purposes. There was a sig-
nificant interaction between Gender/Sex and Gum, multi-
variate F(18,204) = 1.65, p = 0.050, with women’s T% larger
than men’s, so analyses were separate by gender/sex.
One-sample t-tests confirmed no significant difference
from zero in the No Gum condition for women’s T%,
t(9) = 0.60, ns, E%, t(9) = 0.25, ns, or IgA%, t(11) = 1.23,
ns, or men’s T%, t(10) = 0.48, ns, E%, t(9) = 1.60, ns, or
IgA%, t(9) = 1.04, ns. In contrast, there were significant
differences from zero for women’s andmen’s gum-stimulated
analytes (see Fig. 1). Women’s T was significantly increased
Figure 1 Mean percent changes in women’s and men’s T (testosterone), E (estradiol), and IgA (immunoglobulin A) by condition with
standard error bars. Notations indicate within-analyte differences from No Gum condition at ‘ < ’ = p < 0.10, ‘*’ = p < 0.05,
‘**’ = p < 0.01, ‘***’ = p < 0.001. ‘O’ = Orbit, ‘E’ = Extra, ‘D’ = Dentyne; ‘S’ = Spearmint, ‘P’ = Peppermint. Numbers above or below
the bars indicate n’s per group. Percent change in analyte.
Effects of gum on salivary analytes by gender 307by four gums, with magnitudes ranging from 65 to 145%.
There was a statistical trend for women’s E to be increased by
one gum, andwomen’s IgAwas significantly decreased by four
gums with magnitudes ranging from 50 to 68%. Men’s ETable 1 Means and standard errors in brackets for absolute value
(pg/mL), and immunoglobulin A (IgA) (mg/mL) in women and men
T1 T2 E1
No Gum
Women 20.51 (8.22) 19.51 (12.00) 5.52 (3.
Men 117.76 (46.77) 110.29 (33.68) 5.38a (3
Orbit Spearmint
Women 14.42b (8.02) 29.29b (9.50) 2.63 (3.
Men 91.73 (31.89) 107.27 (36.75) 3.43 (1.
Extra Spearmint
Women 16.79b (3.24) 41.78b (16.88) 2.24a (.6
Men 85.77 (41.60) 115.41 (36.87) 3.89a (1
Dentyne Spearmint
Women 17.78a (10.46) 29.61a (18.68) 3.36 (1.
Men 96.32 (35.76) 113.85 (46.40) 3.05 (2.
Orbit Peppermint
Women 32.90 (15.66) 25.97 (17.15) 3.46 (1.
Men 61.85b (29.18) 105.67b (49.85) 4.67b (3
Extra Peppermint
Women 26.04 (14.37) 27.05 (9.08) 5.60 (3.
Men 81.40b (44.47) 129.90b (44.34) 3.73 (3.
Dentyne Peppermint
Women 19.13b (7.07) 34.12b (9.50) 3.31 (.8
Men 90.31 (43.83) 106.32 (35.49) 5.16 (3.
Notes: ‘a’ indicates a trend for a statistical difference between sample
samples 1 and 2 at p < 0.05. Analyses are independent t-tests.was increased significantly by two gums, and potentially
three more, with magnitudes of 54 to 131%. There was
a statistical trend for men’s T to be increased by three gums,
with magnitudes of 76 to 98%. Men’s IgA was significantlys of samples 1 and 2 of testosterone (T) (pg/mL), estradiol (E)
.
E2 IgA 1 IgA 2
37) 5.28 (5.55) 53.36 (32.94) 54.07 (32.45)
.34) 3.09a (2.32) 51.83 (28.13) 67.24 (28.38)
68) 6.09 (5.66) 47.69 (32.27) 19.67 (26.56)
59) 4.93 (2.69) 61.85b (22.26) 25.59b (26.77)
1) 8.63a (5.30) 56.51b (8.68) 23.07b (22.40)
.88) 6.53a (3.57) 64.81 (53.48) 30.20 (35.81)
90) 6.35 (8.31) 32.26 (22.48) 22.82 (25.51)
05) 4.06 (3.05) 62.81a (46.72) 27.44a (32.52)
96) 5.41 (4.94) 51.08b (30.96) 20.87b (26.75)
.56) 7.06b (4.87) 58.23b (20.70) 25.79b (21.79)
77) 8.08 (7.16) 44.19b (24.54) 17.01b (27.18)
09) 6.82 (4.52) 66.60a (51.16) 14.92a (12.53)
7) 5.53 (4.35) 46.70 (42.59) 44.88 (30.62)
70) 6.76 (4.87) 47.17 (41.39) 36.47 (42.00)
s 1 and 2 at p < 0.10. ‘b’ indicates a significant difference between
308 S.M. van Andersdecreased by all gums, with magnitudes of 51 to 70%.
Analyses with absolute values (see Table 1) showed similar
effects of gum with increased T and E, and decreased IgA in
men and women.
2.1. Sample length
Researchers usegumto speed salivaproduction, so I conducted
analyses to compare sample 2 production lengths between the
No Gum and Gum conditions. There was a significant overall
effect of gum on sample production length, F(6,159) = 5.27,
p < 0.001. Participants in each of the Gum conditions
(means ranged from 4.74 min, SD = 3.39 min, to 7.90 min,
SD = 5.13 min) were significantly quicker at producing the
saliva samples than participants in the No Gum condition
(mean = 10.89 min, SD = 5.16 min), all p’s < 0.05.
To confirm that these were not just pre-existing group
differences, I conducted the same analysis on sample 1 pro-
duction lengths.Therewas anoverall significant effect of gum,
F(6,145) = 2.60,p = 0.020,but this couldnotexplain theabove
effects (i.e. that gum made saliva production quicker) since
participants in only one of the six Gum conditions (Dentyne
Peppermint,mean = 7.74 min, SD = 3.69 min) produced signif-
icantly quicker saliva samples than the No Gum condition
(mean = 11.87 min, SD = 5.69 min), p = 0.009. Instead, these
overall differences appeared to reflect that this group had
more rapid productions at times 1 and 2 thanmost of the other
conditions (an effect that might be expected to occur on the
basis of chance). Further, samples 1 and 2 in the No Gum
conditions took similar lengths of time to produce, while
samples 2 in the Gum conditions were more rapidly produced.
Thus, results from this study support researchers’ observations
that gum does significantly decrease the length of time parti-
cipants take to produce saliva samples; in this study, chewing
gum reduced the time to produce a second saliva sample by 3—
6 min. Given this study’s design, however, these data cannot
demonstrate whether gum speeds up a first saliva sample.
3. Discussion
Given chewing gum’s widespread use in biobehavioral sali-
vary research, data from this paper provide important infor-
mation on gum-assay immunoreactivity for T, E, and IgA in
men and women. Findings indicated that chewing gum sig-
nificantly speeds up sample production by 3—6 min, which
may be helpful when time is a critical consideration. Results
also indicated extremely large effects of gums (50—150%) on
women’s and men’s T, E, and IgA relative to a No Gum
condition, and show for the first time that this is not an
effect of producing two samples or passage of time. Further,
gum immunoreactivity was not consistent between analytes,
increasing Tand E readings, but decreasing IgA readings, and
gum led to a larger decrease in women’s relative to men’s T.
Researchers have conducted methodological investiga-
tions into the effects of gum on salivary assays (Lipson and
Ellison, 1989; Dabbs, 1991; Shirtcliff et al., 2000; Granger
et al., 2004), finding some evidence that sugar-free gums,
including the most widely used Trident Original flavor, affect
both salivary Tand E, but findings have been mixed. As such,
the present study provides some of the first clear evidence of
very strong gum immunoreactivity for T, IgA, and E using adesign that controlled for sample production. Differences
with reports of no immunoreactivity (e.g. Dabbs, 1991) may
have resulted from the present study’s use of larger sample
sizes, conservative statistics that minimize Type II error
(incorrectly concluding inertness), and/or difference in
sweetener (e.g. aspartame vs. saccharin).
A limitation of this study is that it was not designed to
examine why chewing gum interacts with assay results. Still,
one possibility is that the gums affect analyte production. A
more plausible possibility is that the gums interact with the
assays. Another limitation is the prohibitive cost of conduct-
ing a study that would include all salivary analytes or chewing
gums, though I attempted to include more analytes and gums
than comparable studies. Additionally, it remains important
to note that results can be assay- or lab-specific (Lipson and
Ellison, 1989), though findings may and often do generalize to
other assays (e.g. Granger et al., 2004).
Results from this study showed very large and non-scaled
gum-assay immunoreactivity, but there are additional impli-
cations. For example, gender/sex is important in methodo-
logical investigations, as immunoreactivity differed for
women and men. Additionally, assay immunoreactivity can
and does differ in degree and direction depending on ana-
lytes, as gum increased T and E values, but decreased IgA
values. More broadly, however, results from this study indi-
cate that there is a need for more methodological investiga-
tions to support evidence-based best practices.
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